We are live on ! Find out more
BWLSA

Blue Water Life Science Advisors Portfolio holdings

AUM $159M
1-Year Est. Return 139.66%
This Fund
S&P 500
This Quarter Est. Return
+64.12%
1 Year Est. Return
+139.66%
3 Year Est. Return
+503.09%
5 Year Est. Return
+228.74%
10 Year Est. Return
AUM
$159M
AUM Growth
+$34M
Cap. Flow
-$29M
Cap. Flow %
-18.29%
Top 10 Hldgs %
100%
Holding
10
New
Increased
3
Reduced
4
Closed
1

Top Buys

Rank Stock Value
1
CDNA icon
CareDx
CDNA
+$5.55M
2
BLLN
BillionToOne Inc
BLLN
+$4.57M
3
QTRX icon
Quanterix
QTRX
+$4.32M

Top Sells

Rank Stock Value
1
GH icon
Guardant Health
GH
+$13.9M
2
TWST icon
Twist Bioscience
TWST
+$13.1M
3
TXG icon
10x Genomics
TXG
+$11.7M
4
TEM
Tempus AI
TEM
+$2.56M
5
NTRA icon
Natera
NTRA
+$2.2M

Sector Composition

Rank Sector Weight
1 Healthcare 100%

No holdings matched the selected filter criteria.

Similar funds

Blue Water Life Science Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Blue Water Life Science Advisors held 10 positions worth $159M, up 27% from $125M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Blue Water Life Science Advisors withdrew a net $29M in Q2 2026, closing 1 position and reducing 4 holdings. Its most notable exit was Twist Bioscience, an estimated $13.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Blue Water Life Science Advisors added an estimated $5.55M to CareDx.

  • Blue Water Life Science Advisors added most to CareDx in Q2 2026, an estimated $5.55M increase.
  • Blue Water Life Science Advisors's biggest Q2 2026 reduction was Guardant Health, cutting an estimated $13.9M.
  • Blue Water Life Science Advisors fully exited Twist Bioscience in Q2 2026, selling an estimated $13.1M.
  • Blue Water Life Science Advisors's ten largest holdings make up 100% of its $159M portfolio in Q2 2026.
  • Blue Water Life Science Advisors opened 0 new positions and closed 1 in Q2 2026.
  • Blue Water Life Science Advisors's portfolio value rose 27% quarter-over-quarter to $159M.

Based on Blue Water Life Science Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.